Figure 3 from Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia

Figure 3 from Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia

<p>Effects of velcrin treatment on SLFN12 protein levels, PDE3A/B binding, and induction of cell death. <b>A,</b> HEL cells were treated with vehicle control (DMSO) or with the indicated doses of BAY 2666605 for 4 or 8 hours. Cell lysates were resolved by SDS-PAGE and immunoblotted...

Full description

Saved in:
Bibliographic Details
Main Author: Jamie N. Guillen Magaña (22630725) (author)
Other Authors: Markella Zannikou (15062817) (author), Aneta Baran (22630728) (author), Sara Small (22630731) (author), Michael Schieber (15118702) (author), Matthew J. Schipma (22630734) (author), Elizabeth T. Bartom (14844705) (author), Masha Kocherginsky (15062841) (author), Diana Saleiro (15062847) (author), Elspeth M. Beauchamp (15491840) (author), Frank Eckerdt (15133895) (author), Leonidas C. Platanias (15062844) (author)
Published: 2025
Subjects:
Cancer
Therapeutic Research and Development
Cellular Responses To Anticancer Drugs
Drug Targets
Leukemias
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items